Protein kinase C: an attractive target for cancer therapy.

Item

http://www.wikidata.org/entity/Q41971372

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Protein kinase C: an attractive target for cancer therapy.

@en

type

Item

label

Protein kinase C: an attractive target for cancer therapy.

@en

prefLabel

Protein kinase C: an attractive target for cancer therapy.

@en

P1476

Protein kinase C: an attractive target for cancer therapy

@en

P2093

Chiara De Ciucis

http://www.w3.org/2001/XMLSchema#string

Cinzia Domenicotti

http://www.w3.org/2001/XMLSchema#string

Maria A Pronzato

http://www.w3.org/2001/XMLSchema#string

Roberta Ricciarelli

http://www.w3.org/2001/XMLSchema#string

Umberto M Marinari

http://www.w3.org/2001/XMLSchema#string

P2860

Involvement of protein kinase Cepsilon (PKCepsilon) in thyroid cell death. A truncated chimeric PKCepsilon cloned from a thyroid cancer cell line protects thyroid cells from apoptosis

FGF-2 protects small cell lung cancer cells from apoptosis through a complex involving PKCepsilon, B-Raf and S6K2

Protein kinase Cdelta is responsible for constitutive and DNA damage-induced phosphorylation of Rad9

Protein kinase C delta induces transcription of the TP53 tumor suppressor gene by controlling death-promoting factor Btf in the apoptotic response to DNA damage

Roles of tyrosine phosphorylation and cleavage of protein kinase Cdelta in its protective effect against tumor necrosis factor-related apoptosis inducing ligand-induced apoptosis

Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling

Protein kinase C-epsilon protects MCF-7 cells from TNF-mediated cell death by inhibiting Bax translocation

PHLiPPing the switch on Akt and protein kinase C signaling

Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia.

The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01

P304

531-567

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/CANCERS3010531

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Barbara Marengo

P577

2011-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258429411

http://www.w3.org/2001/XMLSchema#string

P698

24212628

http://www.w3.org/2001/XMLSchema#string

P932

3756376

http://www.w3.org/2001/XMLSchema#string